Of contrary, other studies described a low expression of SIRT3 as predicting poor prognosis in CRC patients and its upregulation related to metabolic reprogramming and cell death mechanisms in in vitro models [37, 46, 47]. The gene discussed is SIRT3; the disease is colorectal carcinoma.